Green Chemistry in Natural Product Discovery Sustainable Strategies for Drug Development

Madeline Genet^*
*Correspondence: Madeline Genet, Department of Pharmaceutical Sciences, University of Haiti, Port-au-Prince, Haiti, Email:

Keywords

Natural products • Green chemistry • Drug development

Introduction

Natural products, derived from plants, microorganisms and marine organisms, have been a prolific source of bioactive compounds with diverse chemical structures and pharmacological properties. Many of the most successful drugs in clinical use today, including antibiotics, anticancer agents and immunosuppressant, have their origins in natural products. Examples include penicillin, derived from the fungus Penicillium and taxol, originally isolated from the Pacific yew tree. The unique chemical scaffolds and complex molecular architectures found in natural products often make them ideal starting points for drug development efforts. Despite their potential, traditional methods of natural product discovery are often associated with significant environmental drawbacks. The process typically involves extensive extraction and purification steps, which consume large quantities of organic solvents, generate chemical waste and require substantial energy input [1]. Additionally, the overexploitation of natural resources can lead to ecological damage and loss of biodiversity, particularly in regions with high levels of biological diversity.

Description

Green chemistry, also known as sustainable chemistry, is a set of principles and practices aimed at designing chemical processes and products that minimize environmental impact while maximizing efficiency and safety. The twelve principles of green chemistry, as outlined by Anastas and Warner, provide a framework for guiding the development of environmentally benign chemical processes. These principles include the use of renewable feedstocks, the prevention of waste generation, the design of safer chemicals and processes and the use of catalysts to increase reaction efficiency. Integration of green chemistry principles into natural product discovery offers several potential benefits for sustainable drug development:

Sustainable sourcing: Green chemistry encourages the use of renewable feedstocks and sustainable harvesting practices to minimize the environmental impact of natural product extraction [2,3]. This may involve the cultivation of medicinal plants using organic farming methods or the development of alternative sources of natural products, such as microbial fermentation or synthetic biology approaches.

Efficient extraction and purification: Green chemistry emphasizes the use of environmentally friendly solvents and extraction techniques to reduce waste generation and energy consumption during the isolation and purification of natural products. Techniques such as supercritical fluid extraction, microwave-assisted extraction and chromatography with recyclable stationary phases can help improve efficiency and reduce solvent usage.

Atom economy and synthetic efficiency: Green chemistry promotes the design of synthetic routes with high atom economy, minimizing the generation of by-products and maximizing the utilization of starting materials. Strategies such as catalytic transformations, cascade reactions and solvent-free synthesis can help streamline the synthesis of natural product analogs and derivatives, reducing the environmental impact of chemical synthesis.

Green synthesis of natural product analogs: Green chemistry approaches, such as biocatalysis, enzymatic transformations and chemoenzymatic synthesis, offer sustainable alternatives to traditional chemical synthesis methods for producing natural product analogs and derivatives.

Biodegradable and recyclable materials: Green chemistry encourages the use of biodegradable and recyclable materials in drug formulation and delivery systems to minimize environmental pollution and reduce waste generation.

Eco-friendly synthesis routes: Green chemistry principles advocate for the development of eco-friendly synthesis routes for natural product derivatives. This involves the use of renewable starting materials, biocatalysis and catalytic reactions that minimize the use of toxic reagents and solvents. By employing techniques such as microwave-assisted and ultrasound-assisted synthesis, chemists can reduce reaction times and energy consumption while improving product yields and purity.

Biocatalysis and enzyme engineering: Enzymes offer a sustainable alternative to traditional chemical catalysts for synthesizing natural product derivatives. Biocatalytic reactions are typically conducted under mild conditions, using aqueous solvents and biodegradable substrates, resulting in minimal waste generation and environmental impact. Furthermore, advances in enzyme engineering and protein design have enabled researchers to tailor enzymes for specific transformations, expanding the scope of biocatalysis in natural product synthesis.

Green solvents and reaction conditions: Green chemistry advocates for the use of non-toxic, biodegradable solvents and reaction conditions that minimize environmental harm. Solvent-free and water-based reactions are preferred whenever possible, reducing the reliance on volatile organic solvents and hazardous reagents [4,5]. Additionally, the development of sustainable solvent systems, such as ionic liquids and deep eutectic solvents, offers alternatives to traditional organic solvents, further reducing the environmental footprint of chemical synthesis.

Waste minimization and recycling: Green chemistry strategies aim to minimize waste generation and maximize resource efficiency throughout the drug discovery process. This includes the implementation of recycling and recovery processes for solvents, catalysts and other reaction components. Techniques such as membrane separation, crystallization and adsorption can be used to recover and recycle valuable materials, reducing both costs and environmental impact.

Life cycle assessment and green metrics: Green chemistry encourages the use of life cycle assessment (LCA) and green metrics to evaluate the environmental performance of chemical processes and products. By considering the full life cycle of a pharmaceutical compound, from raw material extraction to disposal, researchers can identify opportunities for improvement and optimization. Green metrics such as atom economy, E-factor and carbon footprint provide quantitative measures of environmental impact, guiding decision-making towards more sustainable practices.

Conclusion

The integration of green chemistry principles into natural product discovery represents a promising approach to sustainable drug development. By adopting environmentally benign practices at every stage of the drug discovery process, researchers can minimize the ecological footprint of pharmaceutical development while still harnessing the potential of natural products for therapeutic applications. However, the widespread adoption of green chemistry in the pharmaceutical industry will require. Overall, green chemistry offers a pathway towards more sustainable and environmentally responsible drug discovery practices, ensuring that future generations can continue to benefit from the rich diversity of natural products without compromising the health of our planet.

Acknowledgement

None.

Conflict of Interest

None.

References

1. Zambare, Vasudeo P. and Lew P. Christopher. "Biopharmaceutical potential of lichens." Pharm Biol 50 (2012): 778-798.

Google Scholar, Crossref, Indexed at

2. Seymour, Fabian A., Peter D. Crittenden, Matthew J. Dickinson and Mathieu Paoletti, et al. "Breeding systems in the lichen-forming fungal genus Cladonia." Fungal Genet Biol 42 (2005): 554-563.

Google Scholar, Crossref, Indexed at

3. Nguyen, Khanh-Hung, Marylene Chollet-Krugler, Nicolas Gouault and Sophie Tomasi. "UV-protectant metabolites from lichens and their symbiotic partners." Nat Prod Rep 30 (2013): 1490-1508.

Google Scholar, Crossref, Indexed at

4. Paranagama, Priyani A., EM Kithsiri Wijeratne, Anna M. Burns and Marilyn T. Marron, et al. "Heptaketides from Corynespora sp. inhabiting the cavern beard lichen, Usnea cavernosa: First report of metabolites of an endolichenic fungus." J Nat Prod 70 (2007): 1700-1705.

Google Scholar, Crossref, Indexed at

5. Yang, Bin-Jie, Guo-Dong Chen, Yan-Jun Li and Dan Hu, et al. "A new xanthone glycoside from the endolichenic fungus Sporormiella irregularis." Mol 21 (2016): 764.

Google Scholar, Crossref, Indexed at